Peter M. Hecht
2009 - Ironwood Pharmaceuticals
In 2009, Peter M. Hecht earned a total compensation of $564.3K as Chief Executive Officer at Ironwood Pharmaceuticals.
Compensation breakdown
| Option Awards | $459,880 |
|---|---|
| Salary | $100,000 |
| Other | $4,410 |
| Total | $564,290 |
Hecht received $459.9K in option awards, accounting for 81% of the total pay in 2009.
Hecht also received $100K in salary and $4.4K in other compensation.
Rankings
In 2009, Peter M. Hecht's compensation ranked 6,426th out of 9,885 executives tracked by ExecPay. In other words, Hecht earned more than 35.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,426 out of 9,885 | 35th |
Division Manufacturing | 2,346 out of 3,690 | 36th |
Major group Chemicals And Allied Products | 510 out of 866 | 41st |
Industry group Drugs | 345 out of 638 | 46th |
Industry Pharmaceutical Preparations | 246 out of 446 | 45th |
Source: SEC filing on April 18, 2012.
Hecht's colleagues
We found three more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2009.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019